bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.09.04.674095

Effects of Gallic Acid on Antioxidant Defense System and Nrf2 Signaling in Mice with Benzene-Induced Toxicity: In Vivo, In Vitro, and Computational Study

Abstract

BackgroundBenzene exposure is a well-known cause of toxicity in several tissues, primarily through the generation of reactive oxygen species (ROS) and disruption of redox homeostasis in the bone marrow. The resulting oxidative stress impairs hematopoiesis, weakens antioxidant defenses, and increases cellular damage. The transcription factor Nrf2 plays a central role in counteracting oxidative stress by regulating the synthesis of antioxidant and detoxifying enzymes, however, its activity is tightly controlled through Keap1-mediated degradation. Antioxidant therapy, particularly with the use of phytochemicals like gallic acid, has emerged as a promising strategy to mitigate these effects. Although the antioxidant potential of gallic acid is well documented, there is still limited integrative evidence regarding its molecular mechanism in counteracting oxidative stress. ObjectiveThis study aims to examine the protective effects of gallic acid on antioxidant defenses, oxidative stress biomarkers, and hematological parameters in mice with benzene-induced toxicity, while also evaluating its potential to modulate Nrf2 signaling through molecular docking. MethodsThirty-six mice were randomized into six groups of six animals each. Group A served as the normal control, while the remaining groups (B-F) were orally administered benzene (150 mg/kg body weight) for fourteen days. Groups D, E, and F received simultaneous oral administration of gallic acid at 25, 50, and 100 mg/kg body weight, respectively. Group C received ascorbic acid (50 mg/kg body weight) as a reference, while Group B was not treated and served as the negative control. Biochemical analyses of tissues (erythrocyte, heart, liver, kidney, femur, and spleen) were performed to assess antioxidant enzyme activities (SOD, CAT, GPx, GST), the non-enzymatic antioxidant GSH, and levels of oxidative stress biomarkers (MDA, PCO, NO, PC). Toxicity in hematological parameters were determined from whole blood, while molecular docking was used to evaluate the binding affinity and interactions of gallic acid with the Kelch domain of Keap1. ResultsExposure to benzene significantly reduced antioxidant enzyme activities, depleted GSH and PC, increased MDA, PCO, and NO levels, and altered hematological parameters (WBC, RBC, HGB, HCT, PLT, LYM) in untreated mice at P<.05, which was consistent with oxidative and nitrosative stress. In contrast, treatment with gallic acid significantly restored antioxidant enzyme activities, increased GSH and PC levels, reduced the concentrations of MDA, PCO, and NO, and improved hematological parameters in a manner comparable to ascorbic acid at P<.05. Molecular docking also revealed strong binding affinity (binding energy: -6.8 kcal/mol) and promising interactions of gallic acid within the Keap1 Kelch domain, suggesting a potential mechanism for Nrf2 stabilization and nuclear translocation. ConclusionsOur findings demonstrate that gallic acid improves the cellular antioxidant defense system and provides protection against benzene-induced oxidative stress in mice. In addition, it may also activate Nrf2 signaling by disrupting the Keap1-Nrf2 complex, thus promoting cellular resilience against oxidative stress.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Olatoye, T. I., Afolabi, B. A., Ogundipe, M. O., Adebayo, J. O.. 2025-09-06. Effects of Gallic Acid on Antioxidant Defense System and Nrf2 Signaling in Mice with Benzene-Induced Toxicity: In Vivo, In Vitro, and Computational Study. https://doi.org/10.1101/2025.09.04.674095

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Conjunctive Targeting Links Drug Synergy to Emergent Proteome Structural States

Combinatorial therapies are widely used in the treatment of acute myeloid leukemia (AML) to address disease heterogeneity, adaptive resistance, and rewired signaling and metabolic states. Yet drug prioritization remains largely guided by clinical or phenotypic evidence, while the molecular mechanisms underlying effective drug combinations remain incompletely defined. To narrow this gap, we developed Combinatorial high-ratio Partial proteolysis with reference PRoteome Analysis (CoPPRA), a structural proteomics workflow based on limited proteolysis of cell lysates that profiles drug-associated changes in regional protein accessibility at peptide-level resolution. Here, we applied CoPPRA to ruxolitinib and ulixertinib, individually and in combination, in AML-related cell lysates. Our findings extend conjunctive targeting (CT), a recently proposed mechanism of combinatorial drug action in which combined exposure produces protein targeting patterns not observed with either drug alone. Previously identified through combination-associated changes in protein solubility/stability, CT is examined here at peptide-level resolution through regional differences in proteolytic accessibility. The ruxolitinib-ulixertinib combination produced broad peptide-level accessibility changes, including a subset meeting the predefined criteria for CT. CT candidates predominantly exhibited regional accessibility changes, with altered peptide regions occurring against comparatively small changes across the remaining quantified peptides from the same proteins. MAP2K1 and ATP6V1G1 showed pronounced differences between overlapping peptide sequences, highlighting localized variation in combination-associated accessibility, including an ATP6V1G1 peptide mapping to an annotated helical region. Combination-associated increases in peptide signals were also observed in PIK3R1, BRD4, and PTPN11, linking regional accessibility changes to signaling and transcriptional regulators relevant to AML. Functional enrichment and network analyses further implicated nucleotide and glucose metabolism, ficolin-1-rich granules, ribosome-associated processes, and phagocytic vesicles. These results extend conjunctive targeting from protein-level solubility/stability changes to regional differences in proteolytic accessibility, showing that combination-associated effects can be concentrated within specific peptide regions rather than distributed uniformly across proteins. More broadly, CoPPRA provides a peptide-resolved approach for investigating the molecular features of combinatorial drug action and prioritizing protein regions for subsequent mechanistic validation.

biochemistry↗

Structural and biochemical characterisation of an iterative GCN5-related N-acetyltransferase required for fungal siderophore tailoring

Siderophore-mediated iron acquisition is essential for fungal survival, particularly under iron-limiting conditions. In Aspergillus fumigatus, SidG, a member of the GCN5-related N-acetyltransferase (GNAT) superfamily, catalyses the final step in the biosynthesis of the extracellular siderophore triacetylfusarinine C (TAFC) through sequential acetylation of the precursor fusarinine C (FsC). However, the timing, catalytic mechanism, and functional significance of this modification are not fully understood. Here, we reconstituted SidG activity in vitro and combined native mass spectrometry, X-ray crystallography, molecular dynamics simulations, and site-directed mutagenesis to investigate its catalytic properties. Our analyses demonstrate that SidG selectively binds acetyl-CoA from the cellular milieu and iteratively acetylates the FsC scaffold prior to iron chelation. Structural, biochemical, and molecular dynamics analyses support a direct transfer mechanism, identify key catalytic residues, and demonstrate the strict selectivity of SidG for short-chain acyl-CoA donors. Together, these findings establish the molecular basis for SidG-dependent siderophore tailoring and expand our understanding of GNAT-catalysed transformations in fungal natural product biosynthesis.

biochemistry↗

Reconstitution of +1 nucleosome transcription reveals coordinated functions of SAGA, Mediator, and TFIIH

The +1 nucleosome has emerged as a key regulator of eukaryotic transcription, but how it controls transcription initiation remains poorly understood. Here we reconstitute transcription through the +1 nucleosome using eleven purified yeast factors: RNA polymerase II (Pol II), the six general transcription factors (GTFs), TFIIS, the activator Pho4, and the SAGA and Mediator complexes. The system recapitulates key features of regulation observed in vivo. SAGA, acting with Pho4, directs pre-initiation complex (PIC) assembly to the correct position through its TBP-loading activity. Mediator stimulates transcription when the +1 nucleosome imposes a barrier to PIC formation, consistent with stabilization of productive TFIIH-DNA engagement. Contrary to the prevailing model, SAGA remains bound to the PIC after TBP loading and acetylates the +1 nucleosome within the assembled complex. The isolated PIC-Mediator-SAGA-nucleosome complex is transcriptionally active, and the repressive effect of the nucleosome is relieved by the DNA translocase activity of Ssl2, the TFIIH subunit that opens promoter DNA. TFIIH thus couples promoter melting to remodeling of the +1 nucleosome.

biochemistry↗